Design of MKC-442 (emivirine) analogues with improved activity against drug-resistant HIV mutants.
Two analogues of the nonnucleoside inhibitor of HIV-1 RT, MKC-442 (emivirine), containing different C6 substituents have been designed to be less susceptible to the commonly found drug-resistance mutation of Tyr181Cys. Compound TNK-6123 had a C6 thiocyclohexyl group designed to have more flexibility...
Main Authors: | , , , , , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
1999
|